PROTECT PSP (Priorities for Future Research on Reducing and Stopping Psychiatric Medicines)

There are many unanswered questions about the process of reducing and stopping psychiatric medicines (commonly referred to as 'tapering') and how best to do it. It is important that future research focuses on the questions that are important to people with lived experience of taking and/or stopping any of these medicines, family members, carers/supporters and healthcare professionals.

The PROTECT study team, in partnership with the James Lind Alliance, has set up this Priority Setting Partnership to identify the Top 10 priorities for future research about reducing and stopping psychiatric medicines. This Partnership could help to change the research agenda which will allow future research to focus on the most important questions.

Key documents